|
01 Jun 2023 |
Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd
|
|
01 Jun 2023 |
LTZ Announces over $10 Million Pre-A+ Financing to Advance Development of its Immunotherapy Pipeline to Treat Cancer and Autoimmune Diseases
|
|
25 May 2023 |
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease
|
|
25 May 2023 |
Novo Nordisk and Life Edit Therapeutics Establish Multi-Target Collaboration to Discover and Develop Gene Editing Therapies for Rare and Cardiometabolic Diseases
|
|
24 May 2023 |
Pathos Launches Precision Oncology Pipeline With License of First Phase I Program, a CBP/p300 Inhibitor
|
|
23 May 2023 |
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
|
|
23 May 2023 |
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
|
|
18 May 2023 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) launches Luzsana Biotechnology™ (Luzsana)
|
|
17 May 2023 |
Chinook Therapeutics Announces Partnership with Ionis to Develop Antisense Therapy for Rare, Severe Chronic Kidney Disease
|
|
15 May 2023 |
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis English
|
|
10 May 2023 |
Amgen and TScan Therapeutics announce collaboration to identify novel targets in Crohn's disease
|
|
10 May 2023 |
Sobi to Acquire CTI BioPharma
|
|
10 May 2023 |
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
|
|
09 May 2023 |
Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck
|
|
04 May 2023 |
Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines
|
|
02 May 2023 |
Maze Therapeutics Announces Exclusive Worldwide License Agreement with Sanofi for MZE001, an Oral Substrate Reduction Therapy for the Treatment of Pompe Disease
|
|
01 May 2023 |
Astellas Enters Into Definitive Agreement to Acquire Iveric Bio
|
|
27 Apr 2023 |
ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer
|
|
25 Apr 2023 |
4DMT Acquires Complement Pathway Inhibitor Payload for 4D-175 Product Candidate for Geographic Atrophy
|
|
21 Apr 2023 |
Oncoinvent Announces Two Publications in Special Edition of Frontiers in Medicine Focused on Alpha Radioisotopes
|
|
18 Apr 2023 |
Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics
|
|
18 Apr 2023 |
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
|
|
17 Apr 2023 |
Genmab and argenx Enter Partnership to Advance Antibody Therapies in Immunology and Oncology
|
|
17 Apr 2023 |
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
|
|
13 Apr 2023 |
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity
|
